Let’s Get to the Point.
Unstructured data sets, integrating data from multiple sources and working collaboratively with other departments and organisations to use real world evidence to innovate our drug discovery are the challenges that headline pharma’s priority list.
This February, industry leaders from key pharma companies like Janssen, AstraZeneca & GSKJanssen, AstraZeneca & GSK will be challenging the hype around big data. Big Pharma, Academia and SMEs alike will be drilling down to the real opportunities for pharma to exploit in order to maximise data use and develop innovative drugs
2015 speakers included:
Global Head Commercial Analytics
Senior Director & Head of Medical Affairs
Senior Leader in Global Information Technology Strategy & Governance
Global Director Marketing, Health Information Technology Strategy Leader
Associate Director Scientific Data Management
Senior Research Scientist
Head of Chemistry at the Drug Discovery Unit
Cancer Research UK Manchester Insititute
Senior Life Science Architect
Group Lead of Information Systems for Medicine and Life Sciences
University Medical Centre Mannheim
Project Excellence Director
Luxembourg Centre for Systems Biomedicine
What Others Have to Say
"It’s not just about the volume of data, it’s the complexity of data that we are challenged by."
"Delivered top bang for the buck, and more! Superb."
"The best conference in the London calendar and the place to go to know the cutting edge of the impact of technology on global enterprise."
"If this is your field, all the big players are there."
"Extremely valuable as my company is setting out on an joint Info Governance and e-discovery programme."
"I found this event valuable, even though not all of it was relevant to me or what I do on a daily basis, but the opportunity to discuss issues with other delegates and vendors that gives a different perspective if useful and thought provoking."